首页 | 本学科首页   官方微博 | 高级检索  
检索        

腹腔内注射IL-2重组腺病毒、IL-3重组腺病毒增强化疗药物抗白血病作用的研究
引用本文:于敏,杨建民,孟沛霖,曹雪涛,章卫平.腹腔内注射IL-2重组腺病毒、IL-3重组腺病毒增强化疗药物抗白血病作用的研究[J].中国肿瘤生物治疗杂志,1996,3(3):191-194.
作者姓名:于敏  杨建民  孟沛霖  曹雪涛  章卫平
作者单位:第二军医大学附属长海医院血液科!上海200433(于敏,杨建民,孟沛霖),第二军医大学免疫学教研室!上海200433(曹雪涛,章卫平)
基金项目:国家自然科学基金,优秀中青年人才专项基金(39421009)
摘    要:对实验性白血病小鼠模型大剂量化疗后,直接腹腔注射IL-2重组腺病毒(Ad-IL-2)和/或IL-3重组腺病毒(Ad-IL-3),发现腹腔注射对照腺病毒载体小鼠虽经大剂量化疗,仍有大量白血病细胞浸润至骨髓、血管、肝脏及脾脏。而腹腔注射Ad-IL-2或Ad-IL-3组小鼠肿瘤生长缓慢,注射Ad-IL-2组小鼠脾NK、CTL活性显著提高,注射Ad-IL-3组小鼠腹腔巨噬细胞数量及杀伤活性明显提高,联合应用Ad-IL-2,Ad-IL-3组小鼠抗白血病作用最为明显,骨髓中虽然仍见白血病细胞,但可见较多正常造血细胞,且肝、脾中未见白血病细胞浸润。表明腹腔内注射Ad-IL-2和Ad-IL-3可显著增强大剂量化疗对白血病的治疗效果。

关 键 词:IL-2重组腺病毒  IL-3重组腺病毒  基因治疗  白血病  化疗
收稿时间:1996/2/19 0:00:00
修稿时间:1996/8/10 0:00:00

Enhancing Effects of Intraperitoneal Injection with IL-2 Recombinant Adenovirus and IL-3 Recombinant Adenovirus on the Anti-Leukemia Activity of Chemotherapy
Yu Min,Yang Jianmin,Meng Peilin,Cao Xuetao and Zhang Weiping.Enhancing Effects of Intraperitoneal Injection with IL-2 Recombinant Adenovirus and IL-3 Recombinant Adenovirus on the Anti-Leukemia Activity of Chemotherapy[J].Chinese Journal of Cancer Biotherapy,1996,3(3):191-194.
Authors:Yu Min  Yang Jianmin  Meng Peilin  Cao Xuetao and Zhang Weiping
Institution:Department of Immunology, Second Military Medical University, Shanghai 200433;Department of Immunology, Second Military Medical University, Shanghai 200433;Department of Immunology, Second Military Medical University, Shanghai 200433;Department of Immunology, Second Military Medical University, Shanghai 200433;Department of Immunology, Second Military Medical University, Shanghai 200433
Abstract:The Ad-IL-2 and/or Ad-IL-3 were i. p. injected into experimental leukemic mice after high dose chemotherapy. When Ad - LacZ was i. p. injected into leukemic mice, there were leukemic cells in bone marrow, vessal, liver and spleen. After i. p. injection of Ad-IL-2 and/or Ad-IL-3, the leukemia - bearing mice showed significant inhibition of tumor growth. As i.p. injection of Ad-IL-2, the splenic NK, CTL activity increased; as i. p. injection of Ad - IL - 3, the number and cytotoxicity of peritoneal macrophages were significantly higher than that of the control groups. After i. p. injection of Ad - IL - 2 and Ad - IL - 3 at the same time, the anti - leukemia activity was the best. Though there were less leukemic cells in the bone marrow, there were no leukemic cells in the liver and spleen. Our results suggested that i. p. injection of Ad - IL - 2 and Ad - IL - 3 could significantly enhance the anti - leukemia activity of chemotherapy.
Keywords:Interleukin - 2 recombinant adenovirus  Interleukin - 3 recombinant adenovirus  gene therapy  leukemia
本文献已被 CNKI 维普 等数据库收录!
点击此处可从《中国肿瘤生物治疗杂志》浏览原始摘要信息
点击此处可从《中国肿瘤生物治疗杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号